2.64
-0.18 (-6.38%)
| Previous Close | 2.82 |
| Open | 2.80 |
| Volume | 787,802 |
| Avg. Volume (3M) | 1,099,153 |
| Market Cap | 127,078,736 |
| Price / Earnings (Forward) | 8.49 |
| Price / Sales | 0.470 |
| Price / Book | 98.16 |
| 52 Weeks Range | |
| Earnings Date | 9 Mar 2026 |
| Profit Margin | -4.59% |
| Operating Margin (TTM) | 3.87% |
| Diluted EPS (TTM) | -0.330 |
| Quarterly Revenue Growth (YOY) | 48.80% |
| Current Ratio (MRQ) | 0.820 |
| Operating Cash Flow (TTM) | 15.38 M |
| Levered Free Cash Flow (TTM) | 6.75 M |
| Return on Assets (TTM) | -6.88% |
| Return on Equity (TTM) | -2,243.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | LifeMD, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 0.25 |
|
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 15.99% |
| % Held by Institutions | 37.56% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Jan 2026 | Announcement | LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. |
| 05 Jan 2026 | Announcement | LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill |
| 26 Dec 2025 | Announcement | LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |